EXHIBIT 99.1
Published on July 6, 2018
Exhibit 99.1
JOINT FILING AGREEMENT
Each of the undersigned hereby agrees that this Amendment No. 8 to Schedule 13D is being filed with the U.S. Securities and Exchange Commission on behalf of each of the undersigned pursuant to Rule 13d-1(k) under the U.S. Securities Exchange Act of 1934, as amended.
Date: July 6, 2018
| Mayne Pharma Ventures Pty Ltd | |
|
/s/ Nick Freeman Nick Freeman, Company Secretary
Mayne Pharma International Pty Ltd
|
|
|
/s/ Nick Freeman Nick Freeman, Company Secretary
Mayne Pharma Group Limited
|
|
|
/s/ Nick Freeman Nick Freeman, Company Secretary
|